1. Home
  2. PYPD vs ANY Comparison

PYPD vs ANY Comparison

Compare PYPD & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYPD
  • ANY
  • Stock Information
  • Founded
  • PYPD 2008
  • ANY N/A
  • Country
  • PYPD Israel
  • ANY United States
  • Employees
  • PYPD N/A
  • ANY N/A
  • Industry
  • PYPD Medical/Dental Instruments
  • ANY Finance: Consumer Services
  • Sector
  • PYPD Health Care
  • ANY Finance
  • Exchange
  • PYPD Nasdaq
  • ANY Nasdaq
  • Market Cap
  • PYPD 16.3M
  • ANY 14.7M
  • IPO Year
  • PYPD 2020
  • ANY N/A
  • Fundamental
  • Price
  • PYPD $3.54
  • ANY $0.87
  • Analyst Decision
  • PYPD Buy
  • ANY Strong Buy
  • Analyst Count
  • PYPD 2
  • ANY 1
  • Target Price
  • PYPD $12.00
  • ANY $3.00
  • AVG Volume (30 Days)
  • PYPD 4.8K
  • ANY 239.4K
  • Earning Date
  • PYPD 11-06-2024
  • ANY 11-11-2024
  • Dividend Yield
  • PYPD N/A
  • ANY N/A
  • EPS Growth
  • PYPD N/A
  • ANY N/A
  • EPS
  • PYPD N/A
  • ANY N/A
  • Revenue
  • PYPD N/A
  • ANY $25,026,000.00
  • Revenue This Year
  • PYPD N/A
  • ANY N/A
  • Revenue Next Year
  • PYPD N/A
  • ANY N/A
  • P/E Ratio
  • PYPD N/A
  • ANY N/A
  • Revenue Growth
  • PYPD N/A
  • ANY 121.94
  • 52 Week Low
  • PYPD $2.95
  • ANY $0.57
  • 52 Week High
  • PYPD $9.20
  • ANY $4.09
  • Technical
  • Relative Strength Index (RSI)
  • PYPD 50.62
  • ANY 47.63
  • Support Level
  • PYPD $3.31
  • ANY $0.84
  • Resistance Level
  • PYPD $3.62
  • ANY $1.04
  • Average True Range (ATR)
  • PYPD 0.19
  • ANY 0.06
  • MACD
  • PYPD 0.01
  • ANY -0.00
  • Stochastic Oscillator
  • PYPD 51.25
  • ANY 16.83

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Digital Mining and Service and Product. The Digital Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: